Dynavax Technologies (DVAX) 10.91 $DVAX INVESTOR ALERT:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dynavax Technologies (DVAX) 10.91 $DVAX

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Dynavax Technologies Corporation and Advises Investors to Contact the Firm
BusinessWire - Fri Sep 02, 6:51PM CDT
Goldberg Law PC announces that it is investigating Dynavax Technologies Corporation ("Dynavax" or the "Company" (Nasdaq: DVAX) concerning possible violations of federal securities laws.
DVAX: 10.91 (-5.03)

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Dynavax Technologies Corporation - DVAX
BusinessWire - Fri Sep 02, 5:25PM CDT
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Dynavax Technologies Corporation (NASDAQVAX) resulting from allegations that Dynavax may have issued materially misleading business information to the investing public.
DVAX: 10.91 (-5.03)

Dynavax Reports Second Quarter 2016 Financial Results
Marketwire Canada - Fri Aug 05, 4:52PM CDT
BERKELEY, CA--(Marketwired - August 05, 2016) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the second quarter and six months ended June 30, 2016.
DVAX: 10.91 (-5.03)

Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B
Marketwire Canada - Fri Aug 05, 4:32PM CDT
Advisory Committee Meeting Scheduled for November 16, 2016
DVAX: 10.91 (-5.03)

The Zacks Analyst Blog Highlights: Aratana Therapeutics, Dynavax Technologies, Heron Therapeutics and La Jolla Pharmaceutical
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 8:30AM CDT
The Zacks Analyst Blog Highlights: Aratana Therapeutics, Dynavax Technologies, Heron Therapeutics and La Jolla Pharmaceutical
DVAX: 10.91 (-5.03), HRTX: 17.70 (-0.63), LJPC: 16.15 (-0.33), PETX: 8.81 (-0.11)

Drug Stocks' Earnings to Watch on Aug 5: PETX, DVAX & More
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 9:33AM CDT
What's in store for drug stocks Dynavax, Aratana and others when they report their Q2 results on Aug 5?
DVAX: 10.91 (-5.03), JNJ: 119.32 (+0.24), HRTX: 17.70 (-0.63), GILD: 76.89 (-0.53), LJPC: 16.15 (-0.33), PETX: 8.81 (-0.11)

Dynavax Presents New Efficacy Data on Hepatitis B Vaccine, HEPLISAV-B(TM), in Adults With Type 2 Diabetes at ADA Scientific Sessions
Marketwired - Sat Jun 11, 10:00AM CDT
Pivotal Phase 3 Data Show Investigational Two-Dose Hepatitis B Vaccine Provides a Significantly Higher Rate of Seroprotection Than an Approved Vaccine in Patients With Type 2 Diabetes
DVAX: 10.91 (-5.03)

Coverage of Biotechnology Equities - Pacific Biosciences of California, Peregrine Pharma, Dynavax Technologies and Anavex Life Sciences
PR Newswire - Fri Jun 10, 6:45AM CDT
On Thursday, June 09, 2016, the NASDAQ Composite ended the trading session at 4,958.62, down 0.32%; the Dow Jones Industrial Average edged 0.11% lower to finish at 17,985.19; and the S&P 500 closed at 2,115.48, down 0.17%. ActiveWallSt.com has initiated coverage on the following equities: Pacific Biosciences of California Inc. (NASDAQ: PACB), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), Dynavax Technologies Corporation (NASDAQ: DVAX), and Anavex Life Sciences Corporation (NASDAQ: AVXL). Learn more about these stocks by accessing their free trade alerts at:
DVAX: 10.91 (-5.03), PACB: 8.28 (-0.02), AVXL: 3.05 (+0.02), PPHM: 0.38 (+0.02)

Dynavax to Present at Two Upcoming Investor Conferences
Marketwired - Wed May 18, 6:01AM CDT
BERKELEY, CA--(Marketwired - May 18, 2016) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it will present at two upcoming investor conferences. Information relating to the two presentations follows:
DVAX: 10.91 (-5.03)

Dynavax Technologies Down 16.5% Since SmarTrend Downtrend Call (DVAX)
Comtex SmarTrend(R) - Fri May 13, 1:38PM CDT
SmarTrend identified a Downtrend for Dynavax Technologies (NASDAQVAX) on April 27th, 2016 at $18.36. In approximately 2 weeks, Dynavax Technologies has returned 16.54% as of today's recent price of $15.32.
DVAX: 10.91 (-5.03)

Dynavax Technologies reports 1Q loss
Automated Insights - Mon May 09, 8:05AM CDT
BERKELEY, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Monday reported a loss of $27 million in its first quarter.
DVAX: 10.91 (-5.03)

Dynavax Reports First Quarter 2016 Financial Results
Marketwire Canada - Mon May 09, 8:02AM CDT
BERKELEY, CA--(Marketwired - May 09, 2016) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the first quarter ended March 31, 2016.
DVAX: 10.91 (-5.03)

Does This Upstart Pose a Threat to GlaxoSmithKline?
Todd Campbell, The Motley Fool - Motley Fool - Tue May 03, 7:40AM CDT
SOURCE: GLAXOSMITHKLINE PLC. GlaxoSmithKline plc generates more than $1.2 billion per quarter selling vaccines that are used to treat infectious disease, and one of GlaxoSmithKline's top-selling vaccines is Engerix-B, a vaccine used to prevent...
DVAX: 10.91 (-5.03), GSK: 44.26 (+1.28)

Downgrade Alert for Dynavax Technologies (DVAX)
Comtex SmarTrend(R) - Fri Apr 29, 4:01AM CDT
Dynavax Technologies (NASDAQVAX) was downgraded from Outperform to Sector Perform at RBC Capital today. The stock closed yesterday at $17.53 on volume of 1.1 million shares, above average daily volume of 901,000. Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
DVAX: 10.91 (-5.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 14

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 7

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 8

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 6

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 6

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 8

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 5

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading

Top 5 Most Recently Viewed Articles

Amazon's Stock Target Revision Reflects Continued Growth and Strength

Updated Category News Views 273

Amazon Sees Stock Target Increased by Benchmark Benchmark has recently revised its stock price target for Amazon.com (NASDAQ: AMZN) from $200 to an impressive $215, while also maintaining a Buy rating on the stock. This change comes in the wake of Amazon's stellar financial performance, particularly highlighting its operating income, a critical area of interest for...

Continue Reading
What Investors Need to Know About Synopsys Inc Today

Updated Category News Views 108

The Investor Sentiment Surrounding Synopsys Inc Understanding how investors feel about a company like Synopsys Inc (NYSE: SNPS) can often provide insights into market trends and stock movements. Recently, the short interest for Synopsys has decreased by 3.93%, indicating a potential shift in investor sentiment. Currently, there are about 4.07 million shares sold short,...

Continue Reading
Investing in TransDigm Group: A Five-Year Lookback

Updated Category News Views 296

What $100 Invested Five Years Ago Looks Like A five-year timeline in the stock market can feel like an eternity, especially when it comes to digging into the nitty-gritty of returns. If you dropped a crisp $100 into TransDigm Group (NYSE: TDG) back then, today, that money would sit comfortably at about $216.99. Not too shabby, huh? That’s a solid 16.76% annualized...

Continue Reading
Intercontinental Exchange CFO to Speak at Upcoming Finance Conference

Updated Category News Views 260

Warren Gardiner’s Presentation at Bank of America Securities Intercontinental Exchange, Inc. (NYSE: ICE) has announced that its Chief Financial Officer, Warren Gardiner, will take the stage at the notable Bank of America Securities 2025 Financial Services Conference. This event is anticipated to shine a light on the innovative strategies that ICE employs in the...

Continue Reading
Gambling.com Group Acquires Odds Holdings to Boost Growth

Updated Category News Views 181

Gambling.com Group Expands Its Reach with Odds Holdings Acquisition Gambling.com Group, a leader in digital marketing services for the online gambling sector, is making waves with its recent decision to acquire Odds Holdings, the parent company of the innovative platform OddsJam. This agreement is set to fortify Gambling.com Group's presence within the industry, focusing...

Continue Reading